Dr. Eduardo S. Granato, MD

Dr. Granato practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Granato's NPI, 1821151481, was assigned on December 18, 2006. Dr. Granato graduated from Universidad Autonoma de Ciudad Juarez in 1984. Dr. Granato holds New York license 179085.

Dr. Granato's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Granato's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Granato is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Granato to 3 more home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Granato practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Granato's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Granato is board certified in internal medicine by the American Board of Internal Medicine. Dr. Granato is licensed in New York.

Dmand AI lists acid reflux, acute sinusitis, alzheimer's disease, aneurysm, anxiety, arthritis, asthma and atrial fibrillation and flutter among the conditions Dr. Granato treats.

CMS data shows 1,410 Medicare services from Dr. Granato across 8 procedure codes in 2024, for 332 Medicare patients. Medicare paid $100,162 for them. Every service was in an office.

CMS counts 332 Medicare patients who saw Dr. Granato in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Granato's median patient age at 62, with 32% women.

In 2024, Dr. Granato wrote 4,764 Medicare Part D claims for 550 patients. 89% of them were for generic drugs. CMS names the drug for 4,174 of them, across 86 drugs with 11 or more claims each, at $332,998 in total drug cost. In 2023, CMS named 4,073 claims across 83 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Granato for performance year 2024, reported through an alternative payment model (APM). Dr. Granato accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Granato as offering telehealth.

CMS Open Payments shows 148 general payments to Dr. Granato from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $415.

Dr. Granato graduated from Universidad Autonoma de Ciudad Juarez in 1984. Dr. Granato is a member of ACP.

Dr. Granato is in network with 15 carriers, including Elevance, MVP Health Care and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.